Global challenges of bacterial infections in organ transplantation: assessment of risk factors and predominant bacterial pathogen profiles threatening liver, kidney, heart, and lung transplant recipients
Abstract
Background: Bacterial infections, especially those caused by multidrug-resistant organisms, remain a major threat to the survival of organ transplant recipients. This review aimed to systematically assess the most common bacterial pathogens, risk factors, and prevention strategies in solid organ transplantation (SOT), focusing on liver, kidney, heart, and lung transplants.
Methods: A systematic search was conducted across PubMed, Scopus, Web of Science, and Google Scholar databases for studies published between 2015 and 2024. Studies were selected based on inclusion criteria targeting bacterial infections in human transplant recipients. Data were extracted on infection types, bacterial species, risk factors, immunosuppressive regimens, and antimicrobial prophylaxis.
Results: Among 75 eligible articles, 26 met the inclusion criteria. Escherichia coli, Klebsiella spp., and Pseudomonas aeruginosa were the predominant pathogens in most transplant types. Urinary tract infections were most frequent in kidney transplants, while lung, heart, and liver transplant recipients exhibited broader pathogen diversity, including MRSA, VRE, and Acinetobacter. Major risk factors included immunosuppressive therapy, pre-transplant colonization, prolonged ICU stay, and donor-derived MDR organisms. Antibiotic prophylaxis and immunosuppressive regimens varied across studies, with no universal consensus on optimal protocols.
Conclusions: Bacterial infections significantly impact graft survival and…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.